Home › Funds › TENOR CAPITAL MANAGEMENT Co., L.P. › LGND
TENOR CAPITAL MANAGEMENT Co., L.P. position in LGND
LIGAND PHARMACEUTICALS INC · Health Care
TENOR CAPITAL MANAGEMENT Co., L.P. reported holding 22,613,000 shares of LGND (LIGAND PHARMACEUTICALS INC) in its Q3 2026 13F filing — a position valued at US$38.1M, representing 0.70% of its reported portfolio and ranking #39 among its reported holdings. TENOR CAPITAL MANAGEMENT Co., L.P. first reported this position in Q3 2026.
Last updated: 2026-11-17 · Source: SEC EDGAR Form 13F-HR
How TENOR CAPITAL MANAGEMENT Co., L.P.'s LGND position evolved
TENOR CAPITAL MANAGEMENT Co., L.P. first disclosed a stake in LGND in Q3 2026 at 22,613,000 shares (US$38.1M).
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q3 2026 | 22.61M | $38.08M | New |
About LGND and 13F data
LGND (LIGAND PHARMACEUTICALS INC) is a Health Care company. 49 other funds we track also report a position in LGND — the largest reported positions include CONGRESS ASSET MANAGEMENT CO (US$205.7M), Chicago Capital, LLC (US$172.2M), Stephens Investment Management Group LLC (US$139.4M). Under SEC rules, institutional investment managers with over $100M in assets must file Form 13F within 45 days of each quarter-end, disclosing long positions in US-listed equities. The data excludes short positions, most options and foreign holdings, so treat it as a quarterly snapshot rather than a live position.
Other funds holding LGND
- CONGRESS ASSET MANAGEMENT CO 658.56K sh · $205.71M · Q3 2026
- Chicago Capital, LLC 551.23K sh · $172.19M · Q3 2026
- Stephens Investment Management Group LLC 446.14K sh · $139.36M · Q3 2026
- WOLVERINE ASSET MANAGEMENT LLC 50.37M sh · $84.80M · Q3 2026
- GW&K Investment Management, LLC 241.76K sh · $75.52M · Q3 2026
- RICE HALL JAMES & ASSOCIATES, LLC 223.91K sh · $69.94M · Q3 2026
- NEXT CENTURY GROWTH INVESTORS LLC 192.39K sh · $60.10M · Q3 2026
- Ranger Investment Management, L.P. 185.65K sh · $57.99M · Q3 2026
- ASHFORD CAPITAL MANAGEMENT INC 166.34K sh · $51.96M · Q3 2026
- Granahan Investment Management, LLC 154.32K sh · $48.20M · Q3 2026
- SILVERBACK ASSET MANAGEMENT LLC 25.00M sh · $42.00M · Q3 2026
- Private Capital Management, LLC 124.82K sh · $38.99M · Q3 2026
More on TENOR CAPITAL MANAGEMENT Co., L.P.
FAQ
How long has TENOR CAPITAL MANAGEMENT Co., L.P. held LGND?
TENOR CAPITAL MANAGEMENT Co., L.P. has disclosed LGND holdings in 1 of the last 1 reported quarters, going back to Q3 2026.
What is TENOR CAPITAL MANAGEMENT Co., L.P.'s current position in LGND?
As of Q3 2026, TENOR CAPITAL MANAGEMENT Co., L.P. holds 22.61M shares of LGND (LIGAND PHARMACEUTICALS INC), valued at $38.08M, representing 0.70% of its reported portfolio and ranking #39.
Has TENOR CAPITAL MANAGEMENT Co., L.P. been buying or selling LGND?
In the latest 13F filing (Q3 2026), TENOR CAPITAL MANAGEMENT Co., L.P. newly opened its position in LGND.
Which other funds hold LGND?
Other major institutional holders of LGND include CONGRESS ASSET MANAGEMENT CO, Chicago Capital, LLC, Stephens Investment Management Group LLC, among 49 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.